[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350408-105":59,"doc-detail-350408-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","label-free-pathological-subtyping-of-nonsmall-cell-lung-cancer-using-deep-classification-and-virtual-immunohistochemical-staining","Label-free pathological subtyping of nonsmall cell lung cancer using deep classification and virtual immunohistochemical staining","","Study proposes a label-free workflow for non-small cell lung cancer (NSCLC) subtyping using auto-fluorescence imaging of unstained samples combined with deep learning. The method performs disease recognition for non-cancerous tissue, adenocarcinoma, squamous cell carcinoma, and other subtypes, and generates virtual immunohistochemical stains, including TTF-1 for adenocarcinoma and p40 for squamous cell carcinoma. Evaluation uses intensity and lifetime imaging, achieving high AUC for binary and multiclass classification and producing clinical-grade virtual IHC verified by blinded thoracic pathologists.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/label-free-pathological-subtyping-of-nonsmall-cell-lung-cancer-using-deep-classification-and-virtual-immunohistochemical-staining/350408/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/label-free-pathological-subtyping-of-nonsmall-cell-lung-cancer-using-deep-classification-and-virtual-immunohistochemical-staining/350408.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is label-based immunohistochemical workflow considered time-intensive for NSCLC?","Question",{"text":113,"@type":114},"Current clinical practice relies on multi-step staining and labeling, requiring additional time, labor, specialized expertise, and cost, which can delay diagnosis and treatment decisions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What classes does the proposed approach aim to distinguish?",{"text":118,"@type":114},"It distinguishes non-cancerous tissue, adenocarcinoma, squamous cell carcinoma, and other subtypes using deep learning on unstained auto-fluorescence data.",{"name":120,"@type":111,"acceptedAnswer":121},"How are virtual immunohistochemical stains generated and validated?",{"text":122,"@type":114},"The study generates virtual IHC stains from the deep learning pipeline, including TTF-1 for adenocarcinoma and p40 for squamous cell carcinoma, and evaluates them with blinded assessment by three experienced thoracic pathologists.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350408,1790205953,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","npj | digital medicine Article  \n\n| Published in partnership with Seoul National University Bundang Hospital |  | |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41746-026-02557-x](https://doi.org/10.1038/s41746-026-02557-x) |  |  |\n| Label-free pathological subtyping of nonsmall cell lung cancer using deep classiﬁcation and virtual immunohistochemical staining\u003Cbr> Check for updates |  |  |\n| Zhenya Zang1, DavidA. Dorward2, Katherine E. Quiohilag2, Andrew DJ Wood2, James R. Hopgood3, Ahsan R. Akram1,4  & Qiang Wang1,4  |  |  |\n| The differentiation between pathological subtypes of non-small cell lung cancer (NSCLC) is an essential step in guiding treatment options and prognosis. However, current clinical practice relies on multi-step staining and labelling processes that are time-intensive and costly, requiring highly specialised expertise. In this study, we propose a label-free methodology that facilitates autoﬂuorescence imaging of unstained NSCLC samples and deep learning (DL) techniques to distinguish between non-cancerous tissue, adenocarcinoma (AC), squamous cell carcinoma (SqCC), and other subtypes (OS) . We conducted DL-based classiﬁcation and generated virtual immunohistochemical (IHC) stains, including thyroid transcription factor-1 (TTF-1) for AC and p40 for SqCC. We evaluated these methods using two types of autoﬂuorescence imaging: intensity imaging and lifetime imaging. The results demonstrate the exceptional ability of this approach for NSCLC subtype differentiation, achieving an area under the curve above0.981and0.996for binary-and multiclass classiﬁcation. Furthermore, this approach produces clinical-grade virtual IHC staining, which was blind-evaluated by three experienced thoracic pathologists. Our label-free NSCLC subtyping approach enables rapid and accurate diagnosis without the need for conventional tissue processing and staining. Both strategies can signiﬁcantly accelerate diagnostic workﬂows and support efﬁcient lung cancer diagnosis, without compromising clinical decision-making. |  |  |\n| Lung cancer remains the most commonly occurring and leading cause of cancer-associated mortality globally, accounting for 12.4% of all cancer diagnoses and 18.7% of cancer-related deaths1. Pathological diagnosis, subtyping, and molecular phenotyping are central to effectively managing the disease and informing prognosis. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of newly diagnosed lung cancers2,3, with adenocarcinoma (AC) and squamous cell carcinomas (SqCC) comprising approximately 50% and 30% of NSCLC cases, respectively4. However, distinguishing between these and other subtypes based on morphological features alone can be challenging due to the loss of distinct histological differences in more poorly differentiated carcinomas. Immunohistochemical (IHC) staining is therefore frequently employed to aid in phenotypic classiﬁcation, but this process requires additional time, labour, and cost, | which can impact timely diagnosis and delay treatment decisions. Furthermore, the additional tissue sections required for IHC risk exhausting the limited available cellular material, which is also necessary for downstream DNA and RNA-based molecular proﬁling, thereby increasing the risk of requiring a repeat biopsy. Given advancements in computational power, data-driven algorithms, and efﬁcient imaging modalities that explore cellular function and morphology, a fast and accurate computer-aided classiﬁcation solution is highly desirable to enhance diagnostic efﬁciency and facilitate the rapid diagnosis of label-free, stain-free tissues.\u003Cbr>Deep neural networks (DNNs) have emerged as powerful tools for pattern recognition and have been widely applied to both haematoxylin and eosin (H&E) and IHC sections to aid in lung cancer classiﬁcation over the past decade. Coudray et al.5 leveraged deep learning (DL) to classify three |  |\n\n1Centre for Inﬂammation Research, Institute of Regeneration and Repair, The U","cbCait9YrGfDScDC","https://ap.wps.com/l/cbCait9YrGfDScDC","pdf",5499038,"English","# Background\n## Need for faster, label-free NSCLC subtyping\n# Proposed Method\n## Auto-fluorescence imaging of unstained tissue\n## Deep learning classification\n## Virtual immunohistochemical stain generation\n# Evaluation\n## Intensity imaging\n## Lifetime imaging\n## Blinded pathologist assessment\n# Results and Impact\n## High-performance subtype differentiation\n## Faster diagnosis without conventional staining","[{\"question\":\"Why is label-based immunohistochemical workflow considered time-intensive for NSCLC?\",\"answer\":\"Current clinical practice relies on multi-step staining and labeling, requiring additional time, labor, specialized expertise, and cost, which can delay diagnosis and treatment decisions.\"},{\"question\":\"What classes does the proposed approach aim to distinguish?\",\"answer\":\"It distinguishes non-cancerous tissue, adenocarcinoma, squamous cell carcinoma, and other subtypes using deep learning on unstained auto-fluorescence data.\"},{\"question\":\"How are virtual immunohistochemical stains generated and validated?\",\"answer\":\"The study generates virtual IHC stains from the deep learning pipeline, including TTF-1 for adenocarcinoma and p40 for squamous cell carcinoma, and evaluates them with blinded assessment by three experienced thoracic pathologists.\"}]","Label-free pathological subtyping of nonsmall cell lung cancer using deep classification and virtual immunohistochemical staining | PDF",1790088903,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69fae80c78134ec2128860d79103d7cf.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/236e6482595e61e9cc7b42198a5d9e37.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/598fee65938afcaf8057e70afabc0573.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd67909ae8b1f6ad8545f0a2f4646afa.webp",980,1301]